Zobrazeno 1 - 10
of 29
pro vyhledávání: '"C. Beltrán Calvo"'
Publikováno v:
Farmacia Hospitalaria, Vol 39, Iss 3, Pp 80-91 (2015)
Objective: To compare the relative efficacy of infliximab, adalimumab and golimumab through adjusted indirect treatment comparisons (ITCs). Methods: An exhaustive search was performed until October 2013. Databases consulted were MEDLINE, EMBASE, the
Externí odkaz:
https://doaj.org/article/329dbf46d0ae4b01aba0675da7d0878c
Publikováno v:
Clínica e Investigación en Ginecología y Obstetricia. 42:157-164
Resumen El parto supone un peligro potencial para el bienestar fetal. Se han desarrollado nuevos metodos de monitorizacion continua fetal intraparto como la pulsioximetria y el analisis del electrocardiograma fetal (STAN®). Nuestro objetivo es compa
Autor:
Rocio Rodriguez-Lopez, A.M. Carlos-Gil, C. Beltrán-Calvo, J.E. Martín-López, A. Romero-Tabares
Publikováno v:
Actas Urológicas Españolas. 36:178-185
Resumen Objetivos Sintetizar la evidencia disponible sobre las complicaciones y la capacidad de preservacion nerviosa bilateral de la prostatectomia radical en pacientes con cancer prostatico en funcion del tiempo transcurrido de la biopsia diagnosti
Autor:
J.E. Martín-López, A. Romero-Tabares, Rocio Rodriguez-Lopez, A.M. Carlos-Gil, C. Beltrán-Calvo
Publikováno v:
Actas Urológicas Españolas (English Edition). 36:178-185
Objectives To summarize the available evidence on complications and bilateral nerve preser-vation in radical prostatectomy (RP) in patients according to the time interval from diagnostic biopsy (more or less than 6 weeks). Materials and methods Relev
Publikováno v:
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 16(3)
The available evidence was reviewed to compare the effectiveness of CT colonography with that of colonoscopy for colorectal cancer (CRC) screening.An electronic search was conducted using PubMed, EMBASE, the Cochrane Library and Centre for Reviews an
Publikováno v:
Actas urologicas espanolas. 36(3)
To summarize the available evidence on complications and bilateral nerve preservation in radical prostatectomy in patients according to the time interval from diagnostic biopsy (more or less than six weeks).Relevant studies were identified by using s
Autor:
Vega Coca, MA Castillo Muñoz, R. Ubago Pérez, L Abdel-Kader, M Galvan Banqueri, T. Molina López, A Romero Tabares, C. Beltrán Calvo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A99.1-A99
Background Eculizumab is an orphan drug for Atypical Haemolytic Uremic Syndrome (aHUS). The disease is characterised by non-immune haemolytic anaemia, thrombocytopenia and renal impairment. Purpose To assess the efficacy of eculizumab in adult patien
Autor:
M Galván-Banqueri, R Ubago-Pérez, L Abdel-Kader Martín, A Castillo-Muñoz, T Molina-López, C Beltrán-Calvo, Vega-Coca
Publikováno v:
European Journal of Hospital Pharmacy. 21:A26.1-A26
Background Infliximab, adalimumab, etanercept and ustekinumab are indicated to treat moderate-severe plaque psoriasis in Europe. Purpose To evaluate the relative efficacy of biological drugs in the maintenance phase in adults with moderate-severe pla
Autor:
C Beltrán-Calvo, M Galván-Banqueri, R Isabel-Gómez, F Araujo-Rodríguez, R Ubago-Pérez, T Molina-López, Vega-Coca, L Abdel-Kader Martín, MA Castillo-Muñoz
Publikováno v:
European Journal of Hospital Pharmacy. 21:A59.2-A59
Background Two anti-TNF drugs are approved to treat Crohn’s disease (CD) in Europe: infliximab and adalimumab. Purpose To compare their efficacy and safety in adult patients with moderate to severe non-fistulizing CD. Materials and methods A system
Autor:
T Molina-López, R Ubago-Pérez, L Abdel-Kader Martín, A Castillo-Muñoz, C Beltrán-Calvo, M Galván-Banqueri
Publikováno v:
European Journal of Hospital Pharmacy. 21:A154.1-A154
Background Infliximab, adalimumab, etanercept and ustekinumab are indicated to treat moderate-severe plaque psoriasis in Europe. Purpose To assess the relative safety of biological drugs in the maintenance phase in adult patients with moderate-severe